The present invention relates to new compounds of formula I wherein R
1
, R
2
, R
3
, n, m are defined as in claim 1, a process for their preparation and new intermediates used in the preparation thereof, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the prevention and/or treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3.
本发明涉及公式I的新化合物,其中R1、R2、R3、n、m的定义如权利要求书1中所述,以及其制备过程和用于制备新中间体的新中间体,含有所述治疗活性化合物的制药配方以及所述活性化合物在治疗中的应用,特别是在预防和/或治疗与
糖原合成酶激酶-3相关的痴呆症、阿尔茨海默病和相关疾病方面的应用。